Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NÆSTVED DYREKLINIK 2014 ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.1% 1.1% 0.9% 1.2% 1.1% 1.4% 11.6% 11.6%   Credit score (0-100)   87 85 88 81 83 77 21 21   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   246.7 235.7 571.1 199.4 211.9 55.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,458 7,402 8,120 8,684 8,273 8,453 0.0 0.0   EBITDA   1,573 1,881 2,310 2,010 1,285 883 0.0 0.0   EBIT   1,196 1,471 1,874 1,566 853 564 0.0 0.0   Pre-tax profit (PTP)   1,140.7 1,453.3 1,882.9 1,628.0 752.9 534.2 0.0 0.0   Net earnings   888.4 1,133.6 1,467.5 1,269.5 587.3 419.4 0.0 0.0   Pre-tax profit without non-rec. items   1,141 1,453 1,883 1,628 753 534 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,850 2,940 3,311 3,251 2,950 2,762 0.0 0.0   Shareholders equity total   3,082 3,616 4,483 4,353 3,740 3,659 3,179 3,179   Interest-bearing liabilities   214 23.3 0.0 0.0 1,023 73.6 0.0 0.0   Balance sheet total (assets)   5,180 5,362 7,164 5,669 5,954 5,104 3,179 3,179   Net Debt   -1,025 -1,452 -2,912 -1,170 -934 -1,366 -3,179 -3,179     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,458 7,402 8,120 8,684 8,273 8,453 0.0 0.0   Gross profit growth   7.3% 14.6% 9.7% 7.0% -4.7% 2.2% -100.0% 0.0%   Employees   10 11 11 13 13 14 0 0   Employee growth %   11.1% 10.0% 0.0% 18.2% 0.0% 7.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,180 5,362 7,164 5,669 5,954 5,104 3,179 3,179   Balance sheet change%   -1.4% 3.5% 33.6% -20.9% 5.0% -14.3% -37.7% 0.0%   Added value   1,572.9 1,881.1 2,309.9 2,010.0 1,297.4 882.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -178 -451 -195 -636 -864 -637 -2,762 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   18.5% 19.9% 23.1% 18.0% 10.3% 6.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.9% 27.9% 30.3% 25.7% 15.3% 11.0% 0.0% 0.0%   ROI %   32.9% 41.2% 45.5% 36.5% 19.3% 14.3% 0.0% 0.0%   ROE %   29.2% 33.9% 36.2% 28.7% 14.5% 11.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   59.5% 67.4% 62.6% 76.8% 62.8% 71.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -65.1% -77.2% -126.1% -58.2% -72.6% -154.7% 0.0% 0.0%   Gearing %   6.9% 0.6% 0.0% 0.0% 27.4% 2.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.9% 15.6% 135.9% 0.0% 26.8% 13.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.9 1.2 1.0 0.9 1.1 0.0 0.0   Current Ratio   0.8 1.2 1.3 1.4 1.2 1.4 0.0 0.0   Cash and cash equivalent   1,238.5 1,475.4 2,912.5 1,169.9 1,957.0 1,439.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -319.5 267.3 560.9 512.8 387.8 585.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   157 171 210 155 100 63 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   157 171 210 155 99 63 0 0   EBIT / employee   120 134 170 120 66 40 0 0   Net earnings / employee   89 103 133 98 45 30 0 0